Drug Patents owned by Rockwell Medical Inc
1. Drug name - TRIFERIC
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7857977 | ROCKWELL MEDICAL INC | Packaging of ferric pyrophosphate for dialysis |
Sep, 2027
(4 years from now) | |
| US7816404 | ROCKWELL MEDICAL INC | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
Apr, 2029
(6 years from now) | |
Drugs and Companies using FERRIC PYROPHOSPHATE CITRATE ingredient
Treatment: Method of iron administration to treat patients in need of iron replacement
Dosage: FOR SOLUTION;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 272MG IRON/PACKET | FOR SOLUTION;INTRAVENOUS | Prescription |
2. Drug name - TRIFERIC AVNU
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7816404 | ROCKWELL MEDICAL INC | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
Apr, 2029
(6 years from now) | |
| EP2016940A1 | ROCKWELL MEDICAL INC | Methods For The Preparation And Use Of Ferric Pyrophosphate Citrate Chelate Compositions |
Jul, 2028
(5 years from now) | |
| EP2016940B1 | ROCKWELL MEDICAL INC | Methods For The Preparation And Use Of Ferric Pyrophosphate Citrate Chelate Compositions |
Jul, 2028
(5 years from now) | |
Drugs and Companies using FERRIC PYROPHOSPHATE CITRATE ingredient
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 6.75MG IRON/4.5ML (1.5MG IRON/ML) | SOLUTION;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.